Literature DB >> 28551661

Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis.

Leilei Xia1, Guodong Hu2,3, Thomas J Guzzo2.   

Abstract

AIM: To better evaluate the association between preoperative anemia and outcomes in patients following radical or partial nephrectomy for renal cell carcinoma (RCC).
MATERIALS AND METHODS: A meta-analysis of hazard ratios (HR) was conducted to measure the association between preoperative anemia and all-cause mortality (ACM), cancer-specific mortality (CSM), and disease recurrence (DR) in patients who underwent surgery for RCC.
RESULTS: A total of 14 studies (8,673 patients) met the eligibility criteria. All studies reported survival outcomes using the multivariable Cox proportional hazards model. Pooled results showed that preoperative anemia was associated with increased ACM [HR=2.13, 95% Confidence Interval (CI)=1.48-3.06], CSM (HR=1.91, 95% CI=1.26-2.90), and DR (HR=1.67, 95% CI=1.16-2.40).
CONCLUSION: This meta-analysis indicates that preoperative anemia appears to be associated with earlier recurrence and shorter survival of patients undergoing radical or partial nephrectomy for RCC. Our findings, however, still need to be validated by well-designed prospective studies with larger sample sizes and well-controlled confounding factors. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Renal cell carcinoma; anemia; hemoglobin; meta-analysis; mortality

Mesh:

Year:  2017        PMID: 28551661     DOI: 10.21873/anticanres.11677

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.

Authors:  Ryan Sun; Rodney H Breau; Ranjeeta Mallick; Simon Tanguay; Frederic Pouliot; Anil Kapoor; Luke T Lavallée; Antonio Finelli; Alan I So; Ricardo A Rendon; Adrian S Fairey; Jean-Baptiste Lattouf; Jun Kawakami; Bimal Bhindi; Naveen S Basappa; Lori A Wood; Georg A Bjarnason; Daniel Y C Heng; Rahul K Bansal
Journal:  Can Urol Assoc J       Date:  2021-04       Impact factor: 1.862

2.  Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.

Authors:  Gu-Shun Lai; Jian-Ri Li; Shian-Shiang Wang; Chuan-Shu Chen; Chun-Kuang Yang; Sheng-Chun Hung; Chen-Li Cheng; Yen-Chuan Ou; Kun-Yuan Chiu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

3.  Can we Predict Preoperative Tumor Aggressivity with Hemogram Parameters in Renal Cell Carcinoma? a Novel Calculation Method.

Authors:  Murat Uçar; Sedat Soyupek; Taylan Oksay; Alper Özorak; Ali Akkoç; Murat Topçuoğlu; Murat Demir; Alim Koşar
Journal:  J Med Syst       Date:  2019-12-10       Impact factor: 4.460

4.  Abscopal effect following nivolumab induction in a patient with metastatic renal cell carcinoma-unique pathological features of the primary specimen: A case report.

Authors:  Kanta Hori; Yoshihiko Hirohashi; Toshiki Aoyagi; Narumi Taniguchi; Masashi Murakumo; Haruka Miyata; Toshihiko Torigoe; Takashige Abe; Nobuo Shinohara; Ken Morita
Journal:  Exp Ther Med       Date:  2020-01-03       Impact factor: 2.447

5.  Preoperative anaemia and thrombocytosis predict adverse prognosis in non-metastatic renal cell carcinoma with tumour thrombus.

Authors:  Ruotao Xiao; Chuxiao Xu; Wei He; Lei Liu; Hongxian Zhang; Cheng Liu; Lulin Ma
Journal:  BMC Urol       Date:  2021-02-27       Impact factor: 2.264

6.  HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The İzmir oncology group (IZOG) study.

Authors:  Zeynep Gülsüm Güç; Ahmet Alacacıoğlu; Mehmet Eren Kalender; Utku Oflazoğlu; Sinan Ünal; Yaşar Yıldız; Tarık Salman; Yüksel Küçükzeybek; Mustafa Oktay Tarhan
Journal:  Front Nutr       Date:  2022-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.